Author Topic: (JAMA) Analysis of effectiveness of J&J vaccine for preventing COVID-19  (Read 35 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From JAMA Network Open (November 2, 2021)--"Analysis of the effectiveness of the Ad26.COV2.S adenoviral vector vaccine for preventing COVID-19":


https://bit.ly/3opKvDP


I'm not sure how significant the authors' ties to various drug companies are in this instance but they do exist. However, most articles appearing in medical journals indicate that the authors have some connections with pharmaceutical companies.
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
J&J COVID vaccine on the way out?
« Reply #1 on: December 19, 2021, 09:05:40 pm »

From MedPage Today (December 16, 2021)--"J&J's COVID vaccine on the way out?"


[size=78%]https://bit.ly/3yJL1QX[/size]
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
43 Views
Last post November 13, 2019, 02:49:48 pm
by agate
0 Replies
32 Views
Last post October 08, 2021, 08:57:43 pm
by agate
0 Replies
24 Views
Last post November 26, 2021, 09:31:06 pm
by agate
0 Replies
25 Views
Last post January 01, 2022, 09:09:50 pm
by agate
0 Replies
16 Views
Last post February 22, 2022, 09:25:46 pm
by agate